Left Main Percutaneous Coronary Intervention

Neil Ruparelia, Alaide Chieffo

Research output: Contribution to journalArticlepeer-review


Significant unprotected left main stem (ULMS) disease is in approximately 5% to 7% of patients undergoing coronary angiography. Historically, coronary artery bypass grafting has been the gold standard treatment of these patients. With recent advances in stent technology, adjunctive pharmacotherapy, and operator experience, percutaneous coronary intervention (PCI) is increasingly regarded as a viable alternative treatment option, especially in patients with favorable coronary anatomy (low and intermediate SYNTAX (Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) scores). This article aims to discuss the evidence supporting PCI for ULMS disease, current guidelines, and technical aspects.

Original languageEnglish
JournalInterventional Cardiology Clinics
Publication statusAccepted/In press - 2016


  • Coronary artery bypass grafting
  • Drug-eluting stents
  • Guidelines
  • Heart team
  • Intravascular imaging
  • Left main stem
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Left Main Percutaneous Coronary Intervention'. Together they form a unique fingerprint.

Cite this